Pulike Biological Engineering, Inc. (SHA:603566)

Market Cap	4.73B +11.5%
Revenue (ttm)	1.10B +1.7%
Net Income	143.67M +41.3%
EPS	0.42 +43.4%
Shares Out	341.92M
PE Ratio	33.02
Forward PE	24.50
Dividend	0.40 (2.89%)
Ex-Dividend Date	Oct 17, 2025

Volume	4,805,362
Average Volume	4,436,780
Open	13.32
Previous Close	13.35
Day's Range	13.32 - 13.87
52-Week Range	11.81 - 15.79
Beta	0.48
RSI	52.35
Earnings Date	Apr 29, 2026

About SHA:603566

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 1,551
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603566

Financial Performance

In 2024, SHA:603566's revenue was 1.04 billion, a decrease of -16.77% compared to the previous year's 1.25 billion. Earnings were 92.81 million, a decrease of -46.82%.